Abstract
The pathogenesis and clinical significance of cerebral white matter lesions (WML) remain controversial. Various studies have shown that age, hypertension, diabetes mellitus and a history of stroke or heart disease are the most important factors related to cerebral WML. Other studies suggest that WML are closely related to the development of future strokes and other forms of cerebrovascular disease, such as cognitive impairment, in elderly patients with vascular risk factors, particularly hypertension. Angiotensin receptor blockers are antihypertensive drugs useful for the treatment of hypertension and cardiovascular diseases. Recent data from experimental studies and clinical trials suggest that they could be superior to other antihypertensive therapies in preventing the development of cerebrovascular disease and in reducing the risk of death and recurrences in patients with a previous stroke. This paper reviews the clinical importance of cerebral WML, their relationship with stroke development and data concerning cerebrovascular protection with angiotensin receptor blockers.
Keywords: Cerebral white matter lesions, stroke, angiotensin receptor blockers, hypertension, cerebrovascular disease
Current Drug Therapy
Title: Cerebral White Matter Lesions, Risk of Stroke and Cerebrovascular Protection with Angiotensin Receptor Blockers
Volume: 1 Issue: 1
Author(s): Alejandro d. l. Sierra and Cristina Sierra
Affiliation:
Keywords: Cerebral white matter lesions, stroke, angiotensin receptor blockers, hypertension, cerebrovascular disease
Abstract: The pathogenesis and clinical significance of cerebral white matter lesions (WML) remain controversial. Various studies have shown that age, hypertension, diabetes mellitus and a history of stroke or heart disease are the most important factors related to cerebral WML. Other studies suggest that WML are closely related to the development of future strokes and other forms of cerebrovascular disease, such as cognitive impairment, in elderly patients with vascular risk factors, particularly hypertension. Angiotensin receptor blockers are antihypertensive drugs useful for the treatment of hypertension and cardiovascular diseases. Recent data from experimental studies and clinical trials suggest that they could be superior to other antihypertensive therapies in preventing the development of cerebrovascular disease and in reducing the risk of death and recurrences in patients with a previous stroke. This paper reviews the clinical importance of cerebral WML, their relationship with stroke development and data concerning cerebrovascular protection with angiotensin receptor blockers.
Export Options
About this article
Cite this article as:
Sierra d. l. Alejandro and Sierra Cristina, Cerebral White Matter Lesions, Risk of Stroke and Cerebrovascular Protection with Angiotensin Receptor Blockers, Current Drug Therapy 2006; 1 (1) . https://dx.doi.org/10.2174/157488506775268452
DOI https://dx.doi.org/10.2174/157488506775268452 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Can Statin be a Novel Pharmacophore for Antidiabetic Activity?
Mini-Reviews in Medicinal Chemistry Immunologic Modulations to Enhance Post-Stroke Recovery
Current Immunology Reviews (Discontinued) Assessment of Acute Coronary Syndromes: Focus on Novel Biomarkers
Current Medicinal Chemistry Matricellular Proteins in Myocardial Infarction
Current Cardiology Reviews Sepsis-induced Cardiomyopathy
Current Cardiology Reviews Current Research Issues in the Pharmacokinetics of Antiretroviral Drugs in Children
Current Pediatric Reviews Gender Differences in Ischemic Heart Disease
Recent Patents on Cardiovascular Drug Discovery Prevention of Upper Gastrointestinal Ulcer and Complications in Low-Dose Aspirin Users
Current Pharmaceutical Design Pharmacogenomics: A Tool to Prevent and Cure Coronary Heart Disease
Current Pharmaceutical Design The Vascular Wall and the Haemostatic Balance in Type 1 Diabetic Patients with Nephropathy
Vascular Disease Prevention (Discontinued) Hesperidin Potentiates Ghrelin Signaling
Recent Patents on Food, Nutrition & Agriculture Novel Systemic Drugs for Cutaneous T-Cell Lymphoma
Recent Patents on Anti-Cancer Drug Discovery Nebulizer Therapy in Pulmonology: Review of the Literature
Current Respiratory Medicine Reviews From Gene to Epigene-Based Therapies Targeting the Vascular Endothelium
Current Vascular Pharmacology Pollen Diversity, Antiradical and Antibacterial Activity and Phenolic Contents of some Polish Honeys
Current Nutrition & Food Science Cardiac Protection via Metabolic Modulation: An Emerging Role for Incretin-Based Therapies?
Cardiovascular & Hematological Agents in Medicinal Chemistry Anthracycline-Induced Cardiotoxicity
Cardiovascular & Hematological Agents in Medicinal Chemistry The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi
Current Topics in Medicinal Chemistry The Complement Cascade: New Avenues in Stroke Therapy
Current Vascular Pharmacology Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention
Anti-Cancer Agents in Medicinal Chemistry